Medicare Enrolled
Dr. Manuel Zevallos, MD
Optician · Lynwood, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zevallos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zevallos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zevallos
Dr. Manuel Zevallos is an optician specialist in Lynwood, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zevallos performed 893 Medicare services across 520 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zevallos received a total of $27,880 from 102 pharmaceutical and/or device companies across 1151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zevallos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 893 Medicare services
$27,880 industry payments
Medicare Practice Summary
Medicare Utilization ↗893
Medicare services
Bottom 44% in CA for optician
520
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~47 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
214 | $66 | $192 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
165 | $97 | $274 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
159 | $7 | $12 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
59 | $124 | $312 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
52 | $21 | $60 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
43 | $27 | $67 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
42 | $109 | $280 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
30 | $68 | $156 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $131 | $359 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
23 | $35 | $120 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
20 | $60 | $187 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
19 | $8 | $16 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
16 | $10 | $21 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
15 | $42 | $90 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
11 | $4 | $11 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.4% high complexity
0.0% medium
88.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$27,880
Total received (2018-2024)
Avg $3,983/year across 7 years
Top 7% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
102
Companies
1,151
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,362 (87.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,675 (9.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$843 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,429
2023
$4,922
2022
$4,993
2021
$2,676
2020
$3,125
2019
$5,228
2018
$2,508
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$467
PFIZER INC.
$334
Celgene Corporation
$300
Merck Sharp & Dohme LLC
$293
Eisai Inc.
$252
Daiichi Sankyo Inc.
$245
Takeda Pharmaceuticals U.S.A., Inc.
$241
Incyte Corporation
$223
AstraZeneca Pharmaceuticals LP
$221
Janssen Biotech, Inc.
$197
Astellas Pharma US Inc
$120
SOBI, INC
$118
ABBVIE INC.
$113
Gilead Sciences, Inc.
$106
Bayer Healthcare Pharmaceuticals Inc.
$98
EMD Serono, Inc.
$94
Exelixis Inc.
$82
GlaxoSmithKline, LLC.
$78
GENZYME CORPORATION
$75
BeiGene USA, Inc.
$69
PUMA BIOTECHNOLOGY, INC.
$60
Alexion Pharmaceuticals, Inc.
$58
ADC Therapeutics America, Inc.
$57
Lilly USA, LLC
$55
Karyopharm Therapeutics Inc.
$52
Rigel Pharmaceuticals, Inc.
$45
E.R. Squibb & Sons, L.L.C.
$42
Mirati Therapeutics, Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
PROGENICS PHARMACEUTICALS, INC.
$29
SUN PHARMACEUTICAL INDUSTRIES INC.
$28
ARRAY BIOPHARMA INC
$27
PharmaEssentia USA Corporation
$26
Deciphera Pharmaceuticals Inc.
$25
Kyowa Kirin, Inc.
$25
Genentech USA, Inc.
$24
MorphoSys, US Inc.
$24
TAIHO ONCOLOGY, INC.
$21
SERVIER PHARMACEUTICALS LLC
$20
Agios Pharmaceuticals, Inc.
$19
Top 3 companies account for 24.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Scientific Affairs, LLC
$2,675
Novartis Pharmaceuticals Corporation
$1,933
PFIZER INC.
$1,708
Celgene Corporation
$1,626
E.R. Squibb & Sons, L.L.C.
$1,519
AstraZeneca Pharmaceuticals LP
$1,377
Incyte Corporation
$1,340
Takeda Pharmaceuticals U.S.A., Inc.
$982
Genentech USA, Inc.
$864
Janssen Biotech, Inc.
$773
Eisai Inc.
$731
Merck Sharp & Dohme LLC
$719
Astellas Pharma US Inc
$615
GENZYME CORPORATION
$524
Daiichi Sankyo Inc.
$498
Amgen Inc.
$456
Exelixis Inc.
$432
Gilead Sciences, Inc.
$432
Lilly USA, LLC
$393
Boehringer Ingelheim Pharmaceuticals, Inc.
$374
Pharmacyclics LLC, An AbbVie Company
$340
Karyopharm Therapeutics Inc.
$330
BeiGene USA, Inc.
$328
Merck Sharp & Dohme Corporation
$322
EMD Serono, Inc.
$313
Bayer HealthCare Pharmaceuticals Inc.
$276
Puma Biotechnology, Inc.
$268
GlaxoSmithKline, LLC.
$261
Alexion Pharmaceuticals, Inc.
$238
Bayer Healthcare Pharmaceuticals Inc.
$236
EISAI INC.
$233
Seagen Inc.
$227
Foundation Medicine, Inc.
$217
NOVARTIS PHARMACEUTICALS CORPORATION
$199
SOBI, INC
$190
Kite Pharma, Inc.
$187
Global Blood Therapeutics, Inc.
$180
Rigel Pharmaceuticals, Inc.
$173
ABBVIE INC.
$153
Dendreon Pharmaceuticals LLC
$123
MorphoSys, US Inc.
$109
Ipsen Biopharmaceuticals, Inc
$108
Regeneron Healthcare Solutions, Inc.
$107
Myovant Sciences Inc.
$103
PUMA BIOTECHNOLOGY, INC.
$101
Kyowa Kirin, Inc.
$101
Pharmacyclics LLC, an AbbVie Company
$100
SANOFI-AVENTIS U.S. LLC
$100
Taiho Oncology, Inc.
$97
Mirati Therapeutics, Inc.
$93
PharmaEssentia USA Corporation
$89
Blueprint Medicines Corporation
$88
Agios Pharmaceuticals, Inc.
$85
Aurobindo Pharma USA, Inc.
$76
Clinigen, Inc.
$73
Sobi, Inc
$73
ADC Therapeutics America, Inc.
$72
Clovis Oncology, Inc.
$70
Janssen Pharmaceuticals, Inc
$69
ARRAY BIOPHARMA INC
$68
Jazz Pharmaceuticals Inc.
$66
TAIHO ONCOLOGY, INC.
$65
CTI BioPharma Corp.
$62
Stemline Therapeutics Inc.
$60
AVEO Pharmaceuticals, Inc.
$52
G1 Therapeutics, Inc.
$50
INSYS Therapeutics Inc
$47
Heron Therapeutics, Inc.
$47
Progenics Pharmaceuticals, Inc.
$45
Dova Pharmaceuticals
$44
Amarin Pharma Inc.
$44
Myriad Genetic Laboratories, Inc.
$43
Spectrum Pharmaceuticals Inc.
$41
Secura Bio, Inc.
$34
Acrotech Biopharma Inc.
$31
Novo Nordisk Inc
$31
Apellis Pharmaceuticals, Inc.
$29
PROGENICS PHARMACEUTICALS, INC.
$29
Genmab U.S., Inc.
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$28
Sumitomo Pharma America, Inc.
$28
Pharmacosmos Therapeutics Inc.
$27
Sun Pharmaceutical Industries Inc.
$27
Deciphera Pharmaceuticals Inc.
$25
JAZZ PHARMACEUTICALS INC.
$25
TerSera Therapeutics LLC
$25
RECORDATI_RARE_DISEASES_INC.
$25
EUSA Pharma (US) LLC
$24
TG Therapeutics, Inc.
$23
Array BioPharma Inc.
$23
Epizyme, Inc.,
$22
Innate Pharma, Inc
$20
SERVIER PHARMACEUTICALS LLC
$20
MEDIVATION FIELD SOLUTIONS LLC
$20
GE HealthCare
$19
Seattle Genetics, Inc.
$19
Shire North American Group Inc
$17
West Therapeutics Development, LLC
$16
Advanced Accelerator Applications
$15
Terumo BCT, Inc.
$13
Acceleron Pharma, Inc.
$13
Emmaus Medical, Inc.
$12
Top 3 companies account for 22.7% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALIMTA · ALUNBRIG · AYVAKIT · Aimovig · Alecensa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Endari · Enhertu · Epkinly · FARYDAK · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JANUVIA · JARDIANCE · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · Ozempic · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Phesgo · Pomalyst · Poteligeo · Proleukin · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Repatha · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · SYNAGIS · SYNDROS · Somatuline Depot · Spectra Optia Apheresis System · Stivarga · Subsys · Sylvant · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VYXEOS · Vascepa · Victoza · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for optician in CA.
Geographic Context
Opticians within 10 mi
1,779
Per 100K population
18.1
County median income
$87,760
Nearest hospital
SAINT FRANCIS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zevallos is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zevallos experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Zevallos performed 214 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zevallos receive payments from pharmaceutical companies?
Yes. Dr. Zevallos received a total of $27,880 from 102 companies across 1,151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zevallos's costs compare to other opticians in Lynwood?
Dr. Zevallos's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zevallos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Lynwood
Browse opticians in Lynwood ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology